Brown Deborah Margaret

SEC Form 4 insider trading activity

Brown Deborah Margaret has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 13, 2026.

On the most recent filing, Brown Deborah Margaret is listed as Director at ONCOLYTICS BIOTECH INC. Inside the rolling window, Brown Deborah Margaret reported 1 open-market purchase totaling $21K in ONCY and no open-market sales.

Companies traded

Other insiders at ONCY

Insider Buying

$21K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ONCY
Brown Deborah Margaret
Purchase$21KFeb 13SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Brown Deborah Margaret made?

Brown Deborah Margaret has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does Brown Deborah Margaret trade?

Brown Deborah Margaret has filed SEC Form 4 disclosures for 1 company, including ONCY.

When was Brown Deborah Margaret's most recent SEC Form 4 filing?

Brown Deborah Margaret's most recent SEC Form 4 filing on Tracefour is dated Feb 13, 2026.

What is Brown Deborah Margaret's total buy and sell value in the current window?

Inside the rolling retention window, Brown Deborah Margaret bought $21K and sold $0 based on SEC Form 4 filings.

What was Brown Deborah Margaret's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 25,000 ONCY shares on 2026-02-12, worth $21K, per SEC Form 4 filings.